Pharming Group Quote, Financials, Valuation and Earnings

Pharming Group Price Quote

-0.35 (-2.96%)
(Updated: September 29, 2023 at 6:44 AM ET)

Pharming Group Key Stats

Pharming Group (PHAR) is a Sell

Day range:
$12.13 - $13.40
52-week range:
$8.65 - $17.81
Dividend yield:
P/E ratio:
P/S ratio:
P/B ratio:

Avg. volume:
1-year change:
Market cap:

How Much Does Pharming Group Make?

Is Pharming Group Growing As A Company?

  • What Is Pharming Group's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.09%
  • What Is Pharming Group's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is -0.91%

Pharming Group Stock Price Performance

  • Did Pharming Group Stock Go Up Last Month?
    Pharming Group share price went up by 4.26% last month
  • Did PHAR's Share Price Rise Over The Last Year?
    PHAR share price rose by 21.98% over the past 1 year

What Is Pharming Group 52-Week High & Low?

Pharming Group Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Pharming Group?

  • How Much Debt Does Pharming Group Have?
    Total long term debt quarterly is $136M
  • How Much Cash Does Pharming Group Have?
    Cash and short term investments quarterly total is $192.4M
  • What Is Pharming Group’s Book Value Per Share?
    Book value per share is 3.04

Is Pharming Group Cash Flow Positive?

  • What Is PHAR Cash Flow From Operations?
    Cash flow from operations (TTM) is -$14.6M
  • What Is Pharming Group’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$6.9M
  • What Is Pharming Group’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $19.4M

Pharming Group Return On Invested Capital

  • Is Management Doing A Good Job?
    PHAR return on invested capital is -4.94%
  • What Is Pharming Group Return On Assets?
    ROA measures how assets are converting to revenues and is -4%
  • What Is PHAR Return On Equity?
    ROE is a measure of profitability and is -8.17%

Pharming Group Earnings Date & Stock Price

Pharming Group Competitors

Pharming Group Dividend Yield

Data Unavailable

Pharming Group Analyst Estimates

YoY Growth Past Surprise
EPS: -90.91% 111.77%
Revenue: 9.47% 1.08%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 38.50
Upside from Last Price: 200.31%

Major Shareholders

  • How many PHAR shares are owned by institutional investors?
    27.1K PHAR shares are owned by institutional investors
  • How many PHAR shares are owned by insiders?
    0 PHAR shares are owned by insiders